|Bid||14.45 x 1100|
|Ask||14.49 x 1000|
|Day's Range||14.30 - 14.52|
|52 Week Range||12.32 - 24.98|
|PE Ratio (TTM)||N/A|
|YTD Daily Total Return||7.54%|
|Beta (5Y Monthly)||N/A|
|Expense Ratio (net)||0.75%|
With a greater legislative push to legalize recreational marijuana, cannabis ETFs are soaring to start the year and are likely to continue doing so.
ETFs that track the budding cannabis industry led the charge on Wednesday as Organigram (NasdaqGS: OGI) surged on first-quarter revenue that more than doubled expectations. Among the best performing non-leveraged ...
The Viridian Cannabis Deal Tracker is an information service that monitors capital raise and M&A activity in the legal cannabis industry. Analyzing within 12 key industry sectors, the Viridian Cannabis Deal Tracker provides cannabis companies, investors, and acquirers with the data, trends, and intelligence they need to make informed decisions regarding deal valuations, terms, and structures. Since its inception, the Viridian Cannabis Deal Tracker has tracked and analyzed more than 2,400 capital raises totaling over $29 billion as well as more than 900 M&A transactions.
WAYV, the VC-backed company launched by Eaze’s founder Keith McCarty, and finance and compliance tech company Hypur have partnered up to launch a “credit card-like” B2B technology solution for the cannabis industry. The payments solution, aimed at the entire cannabis supply chain, helps businesses reduce their reliance on cash, move money across the supply chain digitally, and automate compliance and taxes. McCarty told Benzinga WAYV was founded to solve one the biggest problems the legal cannabis industry faces today: finances.
To help put a definitive end to persisting illicit cannabis markets, Uruguay's senate has passed a new bill to regulate medical marijuana. The bill, "A Comprehensive Law for the Promotion and Access to Medical and Therapeutic Cannabis," was introduced into Congress by the "Ir" sector of the “Frente Amplio” party, and approved unanimously. The new bill also presents guidelines for pharmaceutical compounding.
This week on the show, we dive into hot topic in the world of Hip Hop and Politics. Javier Hasse is the author of the book Start Your Own Cannabis Business (Entrepreneur Press 2018), which hit the #1 Best Seller spot on Amazon, as well as a cannabis-focused, award-winning reporter and editor, with more than 4,700 unique articles published across numerous mass media outlets.
Amplify ETFs announces the net asset value (NAV) of the Amplify Seymour Cannabis ETF (NYSE Arca: CNBS) was reduced by $0.2562 per share on Friday, December 6, 2019. This adjustment is a result of an error in calculating the Fund’s NAV.
DETROIT — The premier gathering of cannabis entrepreneurs and investors in North America, the Benzinga Cannabis Capital Conference , is heading to Miami in 2020 for its sixth installment. The conference, ...
A wave of disappointing earnings caused a bloodbath in marijuana ETFs last week. However, talks of an end to the federal embargo on marijuana could turn this segment around.
ETF investors who are interested in the rising cannabis industry should look to the importance of experienced active management when investing in this emerging asset class. On the recent webcast, Investing in Cannabis: What Advisors Need to Know, Christian Magoon, Founder and CEO, Amplify ETFs, outlined the history of cannabis and how the industry has only just begun to gain a firm footing after California became the first state to legalize cannabis in 1996, followed by Washington and Colorado in 2012, and more recently, Canada became the second country in the world to legalize it. Some may have heard of terms like CBD oils, hemp, THC and marijuana.
As governments around the world continue to ease laws on cannabis, this budding industry is creating a big opportunity for early investors. On the upcoming webcast, Investing in Cannabis: What Advisors ...